Literature DB >> 1655594

Small cell carcinoma of the cervix: a clinical and flow-cytometric study.

B Miller1, M Dockter, M el Torky, G Photopulos.   

Abstract

The clinical course of 14 patients diagnosed with small cell carcinoma of the cervix (SCC) was reviewed and compared to that of 37 cases of undifferentiated large cell nonkeratonizing carcinoma (LCNK). We observed the following differences between the two: SCC patients had a higher incidence of pelvic wall involvement and distant metastasis; the development of progressive disease was more frequent in SCC than in LCNK patients; median survival time was 9 months in SCC and 40 months in LCNK patients; flow cytometry revealed aneuploidy in all SCC and in 30% of the LCNK patients; the mean DNA index was 2.24 in SCC, significantly higher than in LCNK (1.15). DNA index in cases of SCC was related to survival time. SCC of the cervix is an extremely aggressive tumor, even when compared to other undifferentiated cervical cancers. Aneuploidy is a consistent feature and thus helpful for diagnosis. Due to the wide range of values, the DNA index cannot be used for diagnostic purposes, but it is of prognostic importance in SCC cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655594     DOI: 10.1016/0090-8258(91)90225-t

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Large cell neuroendocrine carcinoma of female genital tract: a clinicopathological study of two cases with review of literature.

Authors:  Umashankar Prakasam; A K Khader Hussain; P P Ansar; S Ayyappan; Vikas Mahajan; Ganpathy Ramanan
Journal:  Indian J Surg Oncol       Date:  2013-11-13

2.  Natural history and outcome of neuroendocrine carcinoma of the cervix.

Authors:  Benjamin Margolis; Ana I Tergas; Ling Chen; June Y Hou; William M Burke; Jim C Hu; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2016-02-09       Impact factor: 5.482

3.  [Neuroendocrine carcinomas of the cervix].

Authors:  D Schmidt; L-C Horn; F Kommoss
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

4.  Case Report: Circulating Tumor DNA Fraction Analysis Using Ultra-Low-Pass Whole-Genome Sequencing Correlates Response to Chemoradiation and Recurrence in Stage IV Small-Cell Carcinoma of the Cervix - A Longitudinal Study.

Authors:  Ata Abbas; Morgan Gruner; Jennifer Karohl; Peter G Rose; Amy Joehlin-Price; Daniel Stover; Haider Mahdi
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 5.738

5.  Pap smear screening for small cell carcinoma of the uterine cervix: a case series and review of the literature.

Authors:  Hyun Jong Park; Young Mi Choi; Chan Kyung Chung; San Hui Lee; Ga Won Yim; Sang Wun Kim; Eun Ji Nam; Young Tae Kim
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

6.  Neuroendocrine carcinoma of the cervix presenting as intractable hyponatremic seizures due to paraneoplastic SIADH-a rare case report and brief review of the literature.

Authors:  Santhosh Kuriakose; N Umadevi; Sheela Mathew; Nk Supriya; Kp Aravindan; Ds Smitha; G Amritha Malini
Journal:  Ecancermedicalscience       Date:  2014-07-31

7.  Prognostic factors and outcomes of early-stage small cell neuroendocrine carcinoma of the cervix: 37 cases from a single center.

Authors:  Dandan Zhang; Xiaoxin Ma
Journal:  PeerJ       Date:  2019-05-03       Impact factor: 2.984

8.  Small cell carcinoma of cervix: A population-based study evaluating standardized provincial treatment protocols.

Authors:  Soumyajit Roy; Jenny J Ko; Gaurav Bahl
Journal:  Gynecol Oncol Rep       Date:  2019-01-09

9.  Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases.

Authors:  Saliha Sağnıç; Özer Birge; Mehmet Sait Bakır; Ceyda Karadag; Tayup Şimşek
Journal:  Int J Surg Oncol       Date:  2021-09-16

10.  Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.

Authors:  Long Huang; Ling-Min Liao; An-Wen Liu; Jian-Bing Wu; Xiao-Ling Cheng; Jia-Xin Lin; Min Zheng
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.